Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
received Shingrix first dose back in 2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a adult female patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose on 13-SEP-2023 having batch number X9KC7 and expiry date 25-OCT-2024). The patient did not receive the 2nd dose of Shingrix. The patient experienced incomplete course of vaccination (Verbatim: received Shingrix first dose back in 2023). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 30-SEP-2025 This case is linked with US2025125456, reported by same reporter.; Sender's Comments: US-GSK-US2025125456: